Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BE

Go back to Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights

Lantern Pharma (LTRN) Tops Q2 EPS by 2c

August 9, 2023 4:55 PM EDT

Lantern Pharma (NASDAQ: LTRN) reported Q2 EPS of ($0.44), $0.02 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

... More